Referensi Tuberkulosis R-S

1. Rajamanickam, A., Kothandaraman, S. P., Kumar, N. P., Viswanathan, V., Shanmugam, S., Hissar, S., Nott, S., Kornfeld, H., & Babu, S. (2024). Cytokine and chemokine profiles in pulmonary tuberculosis with pre-diabetes. Frontiers in Immunology, 15, 1447161.
2. Rakotomanana, F., Dreyfus, A., Randrianarisoa, M.M., Raberahona, M., Chevallier, E., Andriamasy, H.E., Bernardson, B.A., Ranaivomanana, P., Ralaitsilanihasy, F., Rasoamaharo, M. and Randrianirisoa, S.A., 2024. Prevalence of pulmonary tuberculosis and HIV infections and risk factors associated to tuberculosis in detained persons in Antananarivo, Madagascar. Scientific Reports, 14(1), p.8640.
3. Rani, A.Y.A., Ismail, N., Zakaria, Y. and Isa, M.R., 2024. A scoping review on socioeconomic factors affecting tuberculosis loss to follow-up in Southeast Asia. Med J Malaysia, 79(4), pp.470-476.
4. Rehman Au, Khattak M, Mushtaq U, Latif M, Ahmad I, Rasool MF, Shakeel S, Hayat K, Hussain R, Alhazmi GA, Alshomrani AO, Alalawi MI, Alghamdi S, Imam MT, Almarzoky Abuhussain SS, Khayyat SM and Haseeb A (2023) The impact of diabetes mellitus on the emergence of multi-drug resistant tuberculosis and treatment failure in TB-diabetes comorbid patients: a systematic review and meta-analysis. Front. Public Health 11:1244450.
5. Reid, M., Agbassi, Y.J.P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D. and Churchyard, G., 2023. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. The Lancet, 402(10411), pp.1473-1498.
6. Reta, M.A., Asmare, Z., Sisay, A., Gashaw, Y., Getachew, E., Gashaw, M., Dejazmach, Z., Jemal, A., Gedfie, S., Kumie, G. and Nigatie, M., 2024. Prevalence of pulmonary tuberculosis among key and vulnerable populations in hotspot settings of Ethiopia. A systematic review and meta-analysis. Plos one, 19(8), p.e0309445.
7. Rima, U.S., Islam, J., Mim, S.I., Roy, A., Dutta, T., Dutta, B. and Ferdaus, F.F., 2024. Co-Infection of Tuberculosis and Diabetes: Implications for Treatment and Management. Asia Pacific Journal of Surgical Advances, 1(2), pp.51-58.
8. Rochmah, A.F., Zahroh, C., Nadatien, I., Setiyowati, E., & Hidaayah, N. (2024). Does education influence self-efficacy in tuberculosis patients? A systematic review. Journal of Applied Nursing and Health, 6(1), 128–138.
9. Salindri AD, Auld SC, Gujral UP, et al. Tuberculosis Infection and Hypertension: Prevalence Estimates from the US National Health and Nutrition Examination Survey. BMJ Open. 2024;14:e075176.
10. Salindri, A.D., Haw, J.S., Amere, G.A., Alese, J.T., Umpierrez, G.E. and Magee, M.J., 2021. Latent tuberculosis infection among patients with and without type-2 diabetes mellitus: results from a hospital case-control study in Atlanta. BMC Research Notes, 14(1), p.252.
11. Salindri, A.D., Wang, J.Y., Lin, H.H. and Magee, M.J., 2019. Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002–2013. International Journal of Infectious Diseases, 84, pp.127-130.
12. Sanchini, A., Lanni, A., Giannoni, F. and Mustazzolu, A., 2024. Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive Overview. Tuberculosis, p.102522.
13. Sani, H.A., Hadi, A.J. and Hatta, H., 2025. Key Determinants of Tuberculosis Prevention Behaviors Among Families in Indonesia: A Cross-Sectional Study Analysis. Media Publikasi Promosi Kesehatan Indonesia (MPPKI), 8(2), pp.118-130.
14. Segura-Cerda, C.A., López-Romero, W. and Flores-Valdez, M.A., 2019. Changes in host response to mycobacterium tuberculosis infection associated with type 2 diabetes: beyond hyperglycemia. Frontiers in cellular and infection microbiology, 9, p.342.
15. Septa, D. and Surjadi, L.M., 2023. Glycemic Control Effect on Acid-Fast Bacteria Conversion in Diabetic Patients with Tuberculosis. Jurnal Biomedika dan Kesehatan, 6(1), pp.62-70.
16. Shabil, M., Bushi, G., Beig, M.A., Rais, M.A., Ahmed, M. and Padhi, B.K., 2023. Cardiovascular manifestation in tuberculosis cases: a systematic review and meta-analysis. Current Problems in Cardiology, 48(7), p.101666.
17. Shanmuham, V., Shetty, J.K. and Naik, V.R., 2022. Incidence of tuberculosis in the association of South-East Asia Nation (ASEAN) countries and its relation with health expenditure: a secondary data analysis. Manipal Journal of Nursing and Health Sciences, 8(1), p.7.
18. Shete, P.B., Kadota, J.L., Nanyunja, G., Namale, C., Nalugwa, T., Oyuku, D., Turyahabwe, S., Kiwanuka, N., Cattamanchi, A. and Katamba, A., 2023. Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial. ERJ open research, 9(3).
19. Shewade, H.D., Ravichandran, P., Pradeep, S.K., Kiruthika, G., Shanmugasundaram, D., Chadwick, J., Iyer, S., Chowdhury, A., Tumu, D., Shah, A.N. and Vadera, B., 2024. Bridging the “know-do” gap to improve active case finding for tuberculosis in India: A qualitative exploration into national tuberculosis elimination program staffs’ perspectives. PloS one, 19(11), p.e0309750.
20. Shi H, Yuan Y, Li X, Li YF, Fan L, Yang XM. Analysis of the influencing factors and clinical related characteristics of pulmonary tuberculosis in patients with type 2 diabetes mellitus. World J Diabetes 2024; 15(2): 196-208.
21. Shu, C.C., Hsu, C.L., Wei, Y.F., Lee, C.Y., Liou, H.H., Wu, V.C., Yang, F.J., Lin, H.H., Wang, J.Y., Chen, J.S. and Yu, C.J., 2016. Risk of tuberculosis among patients on dialysis: the predictive value of serial interferon-gamma release assay. Medicine, 95(22), p.e3813.
22. Shu, CC., Wei, YF., Yeh, YC. et al. The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res 21, 51 (2020).
23. Silva, M.T. and Galvão, T.F., 2024. Tuberculosis incidence in Brazil: time series analysis between 2001 and 2021 and projection until 2030. Revista Brasileira de Epidemiologia, 27, p.e240027.
24. Smith, A. G. C., Kempker, R. R., Wassie, L., Bobosha, K., Nizam, A., Gandhi, N. R., Auld, S. C., Magee, M. J., Blumberg, H. M., & Tuberculosis Research Unit: Role of Antigen Specific Responses in the Control of TB (TBRU-ASTRa) Study Group. (2022). The impact of diabetes and prediabetes on prevalence of Mycobacterium tuberculosis infection among household contacts of active tuberculosis cases in Ethiopia. Open Forum Infectious Diseases, 9(7), ofac323.
25. Soemarko, D.S., Halim, F.A., Kekalih, A., Yunus, F., Werdhani, R.A., Sugiharto, A., Mansyur, M., Wingfield, T. and Fuady, A., 2023. Developing a tool to measure tuberculosis-related stigma in workplaces in Indonesia: An internal validation study. SSM-Population Health, 21, p.101337.
26. Soeroto, A.Y., Pratiwi, C., Santoso, P. and Lestari, B.W., 2021. Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study. PloS one, 16(2), p.e0246284.
27. Sofiana, L., Muthiah, T.A.S. and Putri, N. (2024) Analysis of directly observed treatment shortcourse implementation as an effort to control tuberculosis in Yogyakarta. The Indonesian Journal of Public Health, 19(3), pp. 507–519.
28. Solanki HM, Ranpariya PN, Chudasama RK. Health status and treatment outcome of tuberculosis with diabetes mellitus cases, Rajkot City, Gujarat – A longitudinal study. Indian J Community Med 2023;48:75‑81.
29. Song, W.M., Guo, J., Xu, T.T., Li, S.J., Liu, J.Y., Tao, N.N., Liu, Y., Zhang, Q.Y., Liu, S.Q., An, Q.Q. and Li, Y.F., 2021. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019. BMC pulmonary medicine, 21, pp.1-14.
30. Sorokina, M., Ukubayev, T. and Koichubekov, B., 2023. Tuberculosis incidence and its socioeconomic determinants: developing a parsimonious model. Annali di Igiene, Medicina Preventiva e di Comunita, 35(4): 468-479.
31. Ssekamatte P, Sande OJ, van Crevel R and Biraro IA (2023). Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility. Front. Immunol. 14:1122255.
32. Sun H-Y, Wang J-Y, Chen Y-C, Hsueh PR, Chen Y-H, Chuang Y-C, et al. (2020) Impact of introducing fluorescent microscopy on hospital tuberculosis control: A before-after study at a high caseload medical center in Taiwan. PLoS ONE 15(4): e0230067.
33. Suwannacho, R., Anantachina, N. and Sornprom, C., 2024. Glycated hemoglobin level and sputum acid—fast bacilli conversion in pulmonary tuberculosis. The Clinical Academia, 48(3), pp.84-91.
34. Swartwood, N.A., Li, Y., Regan, M., Marks, S.M., Barham, T., Asay, G.R.B., Cohen, T., Hill, A.N., Horsburgh, C.R., Khan, A.D. and McCree, D.H., 2024. Estimated Health and Economic Outcomes of Racial and Ethnic Tuberculosis Disparities in US-Born Persons. JAMA Network Open, 7(9), pp.e2431988-e2431988.
35. Syafiq, N.J.M., Trivedi, A.A., Lai, A., Fontelera, M.P.A. and Lim, M.A., 2023. Latent tuberculosis infection in health-care workers in the government sector in Brunei Darussalam: A cross-sectional study. Journal of Integrative Nursing, 5(3), pp.197-202.
36. Syahrani, F., Lestari, H. and Irma, I., 2025. Faktor Risiko Kejadian TBC pada Usia Produktif di Puskesmas Poasia, Kota Kendari Tahun 2024. Jurnal Kendari Kesehatan Masyarakat, 4(3), pp.221-229.